Figure 3
Ixazomib treatment duration and response. (A) Number of cycles on therapy and response to treatment in patients achieving stable disease or better; (B) individual patients’ best M-protein response to treatment, by treatment cohort.
Ixazomib treatment duration and response. (A) Number of cycles on therapy and response to treatment in patients achieving stable disease or better; (B) individual patients’ best M-protein response to treatment, by treatment cohort.
